CA1287832CCA000615600ACA615600ACA1287832CCA 1287832 CCA1287832 CCA 1287832CCA 000615600 ACA000615600 ACA 000615600ACA 615600 ACA615600 ACA 615600ACA 1287832 CCA1287832 CCA 1287832C
Authority
CA
Canada
Prior art keywords
compound
treatment
viral infections
composition
guanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA000410092Aexternal-prioritypatent/CA1300622C/fr
Application filed by Merck and Co IncfiledCriticalMerck and Co Inc
Application grantedgrantedCritical
Publication of CA1287832CpublicationCriticalpatent/CA1287832C/fr